Indegene IPO
Indegene IPO open for bidding on 6th May 2024, and ends on 8th May 2024.
Indegene Limited specializes in providing digital-led commercialization services to the life sciences industry. The company supports biopharmaceutical, emerging biotech, and medical devices companies with extensive expertise. Their offerings span drug development, clinical trials, regulatory submissions, pharmacovigilance, and innovative sales and marketing strategies.
Indegene’s service portfolio includes Enterprise Commercial Solutions, Omnichannel Activation, and Enterprise Medical Solutions. These solutions deliver comprehensive support from initial drug discovery through to market launch and beyond.
Indegene is a trusted partner of the top 20 largest biopharmaceutical companies worldwide. Operating from hubs across North America, Europe, and Asia, Indegene leverages AI and machine learning technologies to transform the operational capabilities of its clients. This strategic approach positions Indegene as a key player in driving the digital transformation and enhancing patient outcomes in the life sciences sector.
For more details refer to Indegene IPO RHP
Indegene IPO Details
| IPO Date | 6th May 2024 to 8th May 2024 |
| Listing Date | 13th May 2024 |
| Face Value | ₹2 per share |
| Price Band | ₹430 to ₹452 per share |
| Lot Size | 33 Shares |
| Total Issue Size | 4,10,07,779 shares (aggregating up to ₹1841.76 Cr) |
| Fresh Issue | 1,70,75,047 shares (aggregating up to ₹760.00 Cr) |
| Offer for Sale | 2,39,32,732 shares of ₹2 (aggregating up to ₹1081.76 Cr) |
| Employee Discount | ₹30 per share |
| Issue Type | Book Built Issue IPO |
IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor | 1,21,41,102(29.6%) |
| QIB | 78,95,950(19.25%) |
| NII | 61,97,468(15.1%) |
| bNII | 41,31,646(10%) |
| sNII | 20,65,822(5%) |
| Retail | 1,44,60,759(35.26%) |
| Employees | 3,12,500(0.76%) |
| Total | 4,10,07,779(100%) |
Indegene IPO Timeline
| IPO Open | 6th May 2024 |
| IPO Close | 8th May 2024 |
| Basis Of Allotment | 9th May 2024 |
| Initiation of Refunds | 10th May 2024 |
| Credit of Shares to Demat | 10th May 2024 |
| Listing Date | 13th May 2024 |
Fundamentals
Data as of 31st December 2023
| Market Cap | ₹10814.07 Cr | P/E Ratio- Pre IPO | 37.78 |
| RoNW% | 18.23 | P/E Ratio- Post IPO | 33.53 |
| RoCE | – | P/B Ratio | 7.55 |
| Debt to Equity | 0.3 | PAT Margin% | 12.62 |
Indegene IPO Objectives
Company proposes to utilise the Net Proceeds towards funding of the following objects:
- Repayment/prepayment of indebtedness of one of our Material Subsidiaries, ILSL Holdings, Inc.;
- Funding the capital expenditure requirements of our Company and one of our Material Subsidiaries, Indegene, Inc.; and
- General corporate purposes and inorganic growth.
